Thursday, November 16, 2000
Kazimierz Borkowski, PhD
Gerald P. McDole, president and CEO is pleased to announce the appointment of Dr. Kazi Borkowski as the vice-president, medical affairs at AstraZeneca Canada Inc. Dr. Borkowski has extensive experience in industry and academia both in Canada and in the UK. He is a member of the Board of Directors of the Canadian Hypertension Society and the Board of Directors, Canadian Society of Clinical Pharmacology.
AstraZeneca Canada Inc. is the leading pharmaceutical company with a formidable product portfolio spanning seven major therapeutic areas: cardiovascular, gastrointestinal, oncology, pain control, respiratory, central nervous system and infection. The Canadian headquarters and manufacturing facilities are located in Mississauga, Ontario, with a state-of-the-art basic research centre in Montreal, Quebec.
Please visit our website for more information at www.astrazeneca.ca.
Back to top